ロード中...
Inhibition of HER2-integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression
HER2, an oncogenic receptor is overexpressed in about 25-30% of breast cancer patients. HER2 has been shown to play role in tumor promotion by having cross-talk with multiple oncogenic pathways in cancer cells. Our results show that Cucurbitacin B (CuB), a triterpenoid steroidal compound inhibited t...
保存先:
主要な著者: | , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Impact Journals LLC
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4039119/ https://ncbi.nlm.nih.gov/pubmed/24729020 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|